Suchergebnisse - "Douxfils, Jonathan"

PubPharm (10)

1

Durability of humoral and cellular immunity six months after the BNT162b2 bivalent booster

enthalten in: Journal of medical virology | 2024

von Favresse, J. | Gillot, C. | Closset, M. | +6

2

Kinetics and ability of binding antibody and surrogate virus neutralization tests to predict neutralizing antibodies against the SARS-CoV-2 Omicron variant following BNT162b2 booster administration

enthalten in: Clinical chemistry and laboratory medicine | 2023

von Simon, G. | Favresse, J. | Gillot, C. | +6

3

Peri-infection titers of neutralizing and binding antibodies as a predictor of COVID-19 breakthrough infections in vaccinated healthcare professionals : importance of the timing

enthalten in: Clinical chemistry and laboratory medicine | 2023

von Gillot, C. | Bayart, J. | Closset, M. | +5

4

Vaccine-induced binding and neutralizing antibodies against Omicron 6 months after a homologous BNT162b2 booster

enthalten in: Journal of medical virology | 2023

von Favresse, J. | Gillot, C. | Bayart, J. | +6

5

Lung Transplant Recipients Immunogenicity after Heterologous ChAdOx1 nCoV-19-BNT162b2 mRNA Vaccination

enthalten in: Viruses | 2022

von Catry, E. | Favresse, J. | Gillot, C. | +8

6

Assessment of the humoral response in Omicron breakthrough cases in healthcare workers who received the BNT162b2 booster

enthalten in: Clinical chemistry and laboratory medicine | 2022

von Favresse, J. | Dogné, J. | Douxfils, J.

7

Antibody titres decline 3-month post-vaccination with BNT162b2

enthalten in: Emerging microbes & infections | 2021

von Favresse, J. | Bayart, J. | Mullier, F. | +9

8

Dynamics of Neutralizing Antibody Responses Following Natural SARS-CoV-2 Infection and Correlation with Commercial Serologic Tests. A Reappraisal and Indirect Comparison with Vaccinated Subjects

enthalten in: Viruses | 2021

von Gillot, C. | Favresse, J. | Maloteau, V. | +2

9

Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2)

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2021

von Favresse, J. | Bayart, J. | Mullier, F. | +3

10

Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2

enthalten in: Viruses | 2021

von Favresse, J. | Gillot, C. | Di Chiaro, L. | +7

1
[1]